Certain Cholesterol Drugs Show Th... (But in younger people you may get differ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Certain Cholesterol Drugs Show Their Limits

Date:11/5/2007

But in younger people, you may get different results."

"There are a lot of other things going on that just secondary prevention wasn't enough," Bonow said. "It doesn't mean we shouldn't be giving statins."

A second paper was the final analysis of a trial of the failed cholesterol drug torcetrapib. Pfizer Inc. pulled the drug, a CETP inhibitor, from development last December because there was an increased risk of death and other adverse outcomes, including elevated blood pressure. This study, which was released early to coincide with the meeting presentation, will be published in the Nov. 22 issue of the New England Journal of Medicine.

The adverse effects were a mystery to investigators, as the drug had succeeded in raising HDL, or "good" cholesterol levels, while lowering LDL levels.

As it turns out, the drug had unexpected side effects that may explain the paradox, according to the Australian researchers who conducted this latest analysis.

"The researchers are pointing out other things that torcetrapib did in addition to raising HDL, which is what you're trying to do," Bonow explained. "The drug also lowered LDL, but it did other things they were not anticipating."

One of these unintended consequences was to raise aldosterone levels, a hormone that helps keep a balance between sodium and potassium levels. "Aldosterone is a byproduct of angiotensin [a chemical that causes vessels to constrict], which is presumably why blood pressure was elevated," Bonow said.

"This trial leads the way open for further exploration. It neither validates nor invalidates the hypothesis that inhibition of CETP is a beneficial effect, but it will remain a hypothesis unless and until it is tested with CETP inhibitors that do not share the off-target pharmacology of torcetrapib," said study author Dr. Philip Barter, a professor at The Heart Research Institute in Sydney. "I personally look forward to more research
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
3. MU researchers studying model to learn why certain cancers become resistant to drugs
4. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
5. Effectiveness of most PTSD therapies is uncertain
6. Value of Most Post-Traumatic Stress Treatments Uncertain
7. Certain Seizure Patients Need Emergency CT Scan
8. Ipsen and Debiopharm Extend Their Agreement for the Exclusive Commercialization of Decapeptyl(R) (triptorelin pamoate) in Europe and Certain Other Territories
9. New review suggests caution on drugs to raise good cholesterol
10. Ability to cope with stress can increase good cholesterol in older white men, study finds
11. Handling Stress Properly Increases Good Cholesterol

Post Your Comments:

Related Image:

Certain Cholesterol Drugs Show Their Limits

(Date:5/22/2013)... May 22, 2013 Hurricane preparation isn’t ... home. That’s why Amica Insurance is reminding ... the upcoming hurricane season. , “An important part of ... Cook, a senior assistant vice president at Amica Insurance. ... before the threat of a storm.” , Flood damage ...

(Date:5/22/2013)... trustworthy, loving child care is one of the most important ... parents in their search, Paty’s Daycare has launched a ... staff and much more. , “Our new website is vibrant, ... Patricia “Auntie Paty” Sutton, founder of Paty’s Daycare. “Just as ... from the first time that you walk through the front ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...

(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... who die each year awaiting an organ donation dropped ... numbers of children are receiving donor organs. During ... expanded to include not just patients who,ve experienced brain ... death." But it,s unclear how much that shift ...

(Date:5/22/2013)... oil supplements could help reduce the risk for ... The supplements, also known as omega-3 fatty acids, ... linked to insulin sensitivity, Harvard researchers found. Higher ... also been linked to a lower risk for ... fish oil increased circulating adiponectin, whether similar effects ...

Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2 Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2 Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3 Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4 Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2

[0] Reviewing Insurance Policies: a Key Part of Hurricane Preparations [0] Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care [0] Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats [0] More Kids Getting Donor Organs, But Gaps Persist, Study Finds [0] Fish Oil Pills Might Cut Diabetes Risk, Researchers Say

... Ill., Nov. 12 Pregis Corporation, a leading international ... specialty packaging solutions, today announced its 2009 third quarter ... of 2009, the Company generated net sales of $207.0 ... $265.2 million in the third quarter of 2008. Excluding ...

... protein involved in blood-brain barrier , THURSDAY, Nov. 12 ... on the brain, but it,s too early to say ... researcher reports. , Fredrik Soderqvist, of Orebro University, analyzed ... they had elevated levels of a protein called transthyretin, ...

... eating dark version lowered levels of stress hormones , THURSDAY, ... dark chocolate could cheer you right up by lowering your ... who report their findings in the online issue of the ... said they were highly stressed. , "The study provides strong ...

... ... P.C. has opened its new facility in Lake Success, NY. The facility will ... Epilepsy Neurologist Alan B. Ettinger, M.D., Neuro-Ophthalmologist Scott Uretsky, M.D., Neuropsychologist Gad E. ... children’s facility designed for the needs of pediatric patients. , ...

... Healthcare is an industry faced with unprecedented uncertainty. ... overcome the noise and clearly communicate relevant and timely ... company Griffin York & Krause (GY&K) reaffirmed its commitment ... been honored with six national CardioVascular Advertising (CVA) Awards. ...

... BEACH, Fla., Nov. 12 Commerce Online Inc. (Pink ... company specializing in both bricks and mortar and online ... partnership with RedFin Network, Inc. ( www.redfinnet.com ... Inc. (OTC Bulletin Board: SFNL), to launch its ...

Pregis Announces Third Quarter 2009 Financial Results Wireless Phones Alter Levels of Brain Chemical Chocolate Soothes the Stressed-Out Soul Neurological Surgery, P.C., of Long Island, NY, Adds New Specialists and Opens New Flagship Facility in Lake Success, NY Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks 'Are You Relevant?'Commerce Online Announces Agreement With RedFin Network For Medical Marijuana Dispensary Pre-Paid Loyalty Card Program

(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...

(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...

(Date:5/22/2013)... Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company ... medical needs, today announced the appointment of ... Board of Directors. Dr. Almenoff has extensive experience in ... drug development. "We are delighted to ... Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise ...

Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5 Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6 Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2 Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3

[0] Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance [0] Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives [0] Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors

... LOUIS, May 2, 2012 Stereotaxis, Inc. (NASDAQ: ... release financial results for the first quarter 2012 ... of the U.S. financial markets. The Company will ... a.m. Eastern Time that day to discuss the ...

... OMER ), a biopharmaceutical company committed to ... and disorders of the central nervous system, today announced ... officer, is scheduled to present at the Deutsche Bank ... presentation is scheduled for 10:00 a.m. Eastern Time on ...

Cached Medicine Technology:Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 2 Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 3

Stereotaxis to Report First Quarter 2012 Financial Results on May 8, 2012 Omeros to Present at Deutsche Bank Securities Health Care Conference

... is a service that directly connects ... the customers laboratory to the Thermo ... U.S.A., and Runcorn, U.K.* By using ... customer site, high-value support services are ...

... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...

... The Shandon Gross-Star Grossing Workbench ... workbench designed for gross examination and ... steel construction, downdraft ventilation with a ... foot pedal controls for cold/hot water ...

... HypercleanTM 22 fume containment system ... a one- or two-person work ... containment system comes complete ... four charcoal filters. (For replacement ...

Medicine Products:

Shandon Excelsior Netmon Service Shandon Grosslab Senior Grossing Workstation Shandon Gross-Star Grossing Workbench Shandon Hyperclean 22 Fume Handling Station